Overview
Corporate Presentation
Email Alerts
Register to receive real time alerts
IR Contacts
Get in touch with our IR team
![]() |
We are developing the investigational therapy Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions by targeting the central and peripheral nervous systems.
Our novel oral formulation has the potential to unlock new market opportunities and significantly improve the quality of life of patients who currently have few treatment options.
Register to receive real time alerts